RUNX3/CBFA3 Antibody [Alexa Fluor® 405]

• Reactivity: Hu
• Applications: WB, ICC/IF
• Clonality: Polyclonal
• Host: Goat
• Conjugate: Alexa Fluor 405

RUNX3/CBFA3 Antibody [Alexa Fluor® 405] Summary

• Immunogen: E. coli-derived recombinant human RUNX3/CBFA3
  Lys186-Tyr415
  Accession # Q13761
• Specificity: Detects human RUNX3/CBFA3 in direct ELISAs and Western blots. In direct ELISAs and Western blots, this antibody shows less than 1% cross‑reactivity with recombinant human (rh) CBFA1 and rhCBFA2.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for RUNX3/CBFA3 Antibody [Alexa Fluor® 405]

• Acute myeloid leukemia 2 protein
• AML2
• AML2SL3/AKV core-binding factor alpha C subunit
• CBFA3
• CBFA3MGC16070
• CBF-alpha-3
• PEA2 alpha C
• PEA2-alpha C
• PEBP2 alpha C
• PEBP2A3
• PEBP2A3FLJ34510
• PEBP2AC
• PEBP2-alpha C
• runt domain, alpha subunit 3
• runt-related transcription factor 3
• RUNX3
• SL3-3 enhancer factor 1 alpha C subunit
• transcription factor AML2

Background

RUNX3, also known as CBFA3 and PEBP2 alpha (polyomavirus enhancer binding protein 2 alpha ) is a member of the runt-related (RUNX) family of transcription factors. It is the DNA binding subunit of the heterodimeric transcription factor CBF/PEBP2. RUNX3 is a nuclear effector of the BMP/TGF-beta pathways and its inactivation or reduced expression is associated with numerous human malignancies. Two isoforms that differ in their N-terminal 5/19 residues have been reported. The 415 amino acid residue of human RUNX3 shares 91% amino acid sequence homology with mouse or rat RUNX3.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.